scholarly journals Fertility Preservation for Prepubertal Patients at Risk of Infertility: Present Status and Future Perspectives

2021 ◽  
pp. 1-10
Author(s):  
Valentina Pampanini ◽  
Jasmin Hassan ◽  
Elizabeth Oliver ◽  
Jan-Bernd Stukenborg ◽  
Pauliina Damdimopoulou ◽  
...  

The increasing cure rate of cancer has led to a vast population of survivors having to face the late adverse effects of oncological treatments, with fertility impairment being one of the most sensitive issues for patients. Different options to preserve the fertility of adult patients are routinely used in clinical practice. However, fertility preservation strategies for prepubertal patients at risk of infertility are limited to the cryopreservation of immature gonadal tissue. In recent decades, many research efforts have been focused on the future use of cryopreserved gonadal tissue. This review discusses the common status of fertility preservation measures for pediatric patients undergoing gonadotoxic treatment, focusing especially on the challenges that remain to be solved in order to implement this fundamental service.

Author(s):  
Laura Fletcher ◽  
Tammy Pham ◽  
Maguire Herriman ◽  
Bridget Kiely ◽  
Ruth Milanaik

2017 ◽  
Vol 2 (1) ◽  
pp. 55-70
Author(s):  
Magda Mohsen ◽  
Omayma OKby ◽  
Reda Elfeshawy

2006 ◽  
Vol 13 (8) ◽  
pp. 840-847 ◽  
Author(s):  
N. Ewen Wang ◽  
Michaela Kiernan ◽  
Mana Golzari ◽  
Michael A. Gisondi

2017 ◽  
Vol 41 (4) ◽  
pp. 209-215 ◽  
Author(s):  
P. García-Soler ◽  
J.M. Camacho Alonso ◽  
J.M. González-Gómez ◽  
G. Milano-Manso

Author(s):  
Luana Lavieri ◽  
Christa Koenig ◽  
Nicole Bodmer ◽  
Philipp Agyeman ◽  
Katrin Scheinemann ◽  
...  

Background Fever in neutropenia (FN) remains a frequent complication in pediatric patients undergoing chemotherapy for cancer. There are only conflicting and weak recommendations for and against antibiotic prophylaxis during chemotherapy. Procedure Pediatric patients were observed in a prospective multicenter study (NCT02324231). A score predicting the risk to develop FN with safety relevant events (SRE; bacteremia, severe sepsis, intensive care unit admission, death) was developed using multivariate mixed Poisson regression. Its predictive performance was assessed by internal cross-validation and compared with the performance of published rules. Results In 238 patients, 318 FN episodes were recorded, including 53 (17%) with bacteremia and 68 (21%) with SRE. The risk prediction score used three variables: chemotherapy intensity, time since diagnosis and type of malignancy. Its cross-validated performance, assessed by the time needed to cover (TNC) one event, exceeded the performance of published rules. Two clinically useful score thresholds were found: a threshold of ≥11 resulted in 2.3% time at risk and 4.1 months TNC; a threshold of ≥8 in 24.9% time at risk and 12.1 months TNC. Using external information on efficacy and timing of intermittent antibiotic prophylaxis, 4.3 months of prophylaxis were needed to prevent one FN with bacteremia, and 5.2 months to prevent one FN with SRE, using a threshold of ≥11. Conclusions This score, based on three routinely accessible characteristics, accurately identifies pediatric patients at risk to develop FN with SRE during chemothearpy. The score can help to design clinical decision rules on targeted primary antibiotic prophylaxis and corresponding efficacy studies.


2014 ◽  
Vol 05 (02) ◽  
pp. 313-333 ◽  
Author(s):  
W.L. Spires ◽  
T.A. Mottes ◽  
J.K. Schaffzin ◽  
C. Barclay ◽  
S.L. Goldstein ◽  
...  

Summary Background: Nephrotoxic medication-associated acute kidney injury (NTMx-AKI) is a costly clinical phenomenon and more common than previously recognized. Prior efforts to use technology to identify AKI have focused on detection after renal injury has occurred. Objectives: Describe an approach and provide a technical framework for the creation of risk-stratifying AKI triggers and the development of an application to manage the AKI trigger data. Report the performance characteristics of those triggers and the refinement process and on the challenges of implementation. Methods: Initial manual trigger screening guided design of an automated electronic trigger report. A web-based application was designed to alleviate inefficiency and serve as a user interface and central workspace for the project. Performance of the NTMx exposure trigger reports from September 2011 to September 2013 were evaluated using sensitivity (SN), specificity (SP), positive and negative predictive values (PPV, NPV). Results: Automated reports were created to replace manual screening for NTMx-AKI. The initial performance of the NTMx exposure triggers for SN, SP, PPV, and NPV all were 0.78, and increased over the study, with all four measures reaching 0.95 consistently. A web-based application was implemented that simplifies data entry and couriering from the reports, expedites results viewing, and interfaces with an automated data visualization tool. Sociotechnical challenges were logged and reported. Conclusion: We have built a risk-stratifying system based on electronic triggers that detects patients at-risk for NTMx-AKI before injury occurs. The performance of the NTMx-exposed reports has neared 100% through iterative optimization. The complexity of the trigger logic and clinical work-flows surrounding NTMx-AKI led to a challenging implementation, but one that has been successful from technical, clinical, and quality improvement standpoints. This report summarizes the construction of a trigger-based application, the performance of the triggers, and the challenges uncovered during the design, build, and implementation of the system. Citation: Kirkendall ES, Spires WL, Mottes TA, Schaffzin JK, Barclay C, Goldstein SL. Development and performance of electronic acute kidney injury triggers to identify pediatric patients at risk for nephrotoxic medication-associated harm. Appl Clin Inf 2014; 5: 313–333 http://dx.doi.org/10.4338/ACI-2013-12-RA-0102


Circulation ◽  
1997 ◽  
Vol 96 (8) ◽  
pp. 2641-2648 ◽  
Author(s):  
Steven E. Lipshultz ◽  
Nader Rifai ◽  
Stephen E. Sallan ◽  
Stuart R. Lipsitz ◽  
Virginia Dalton ◽  
...  

2019 ◽  
Vol 15 (1) ◽  
pp. 61.e1-61.e6
Author(s):  
T.W. Gaither ◽  
C.S. Cooper ◽  
Z. Kornberg ◽  
L.S. Baskin ◽  
H.L. Copp

2016 ◽  
Vol 177 ◽  
pp. 191-196 ◽  
Author(s):  
Aarti Dalal ◽  
Richard J. Czosek ◽  
Joshua Kovach ◽  
Johannes C. von Alvensleben ◽  
Santiago Valdes ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document